Metraipolis › archive › dc_fd285ab52020
Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World… — Europe PMC PMID:41590501
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41590501
- DOI
- 10.3390/jpm16010008
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T07:26:11.834Z
- SHA-256 of the archived text
9002ee0c6864ebd02358dc57e3c16e2b09191c281e75931fa8f1a760797cfa0d- Stable URL of this page
https://metraipolis.com/documento/dc_fd285ab52020
How to cite
Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World… — Europe PMC PMID:41590501 — Europe PMC (en), https://europepmc.org/article/MED/41590501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd285ab52020 (Metraipolis archive dc_fd285ab52020, sha256 9002ee0c6864ebd02358dc57e3c16e2b09191c281e75931fa8f1a760797cfa0d)
BibTeX
@misc{dcfd285ab52020,
title = {Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World… — Europe PMC PMID:41590501},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41590501},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd285ab52020; sha256 9002ee0c6864ebd02358dc57e3c16e2b09191c281e75931fa8f1a760797cfa0d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41590501. Agents can read the archived copy with the MCP tool read_document.